Gene Editing Therapy Shows Significant Reduction in LDL Cholesterol

A novel gene editing treatment has demonstrated considerable success in lowering "bad" cholesterol levels by as much as 62% after a single application. This innovative development presents a promising new strategy for addressing high cholesterol. It could potentially mitigate associated cardiovascular health risks.